Neuraxis Inc (NRXS) Peer Comparison

$6.04

$-1.34 (-18.16%)

As on 26-Aug-2026 16:00EDT

Market cap

$77 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

11.7

Div. Yield

0 %

Edit

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Market cap ($ Mln)	77	2,920	2,195	914	839
Revenue ($ Mln)	5	450	549	--	366
Net Profit ($ Mln)	-7.87	-188.21	17.88	-175.85	9.27
Net Margin (%)	-148.04	-41.86	3.26	--	2.53
RoE (%)	-155.31	-28.46	1.43	-106.84	3.39
Price to Earnings	--	--	126.30	--	84.64
Price-To-Book	11.70	4.82	1.73	5.59	3.06

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Operating Revenue	5.32	449.61	549.12	0.00	366.45
Cost of Revenue	0.77	195.71	548.01	12.78	49.36
Gross Profit	3.01	269.08	212.72	-17.67	330.63
Operating Expenses	12.23	517.90	35.89	176.86	304.74
Operating Profit (EBIT)	-7.68	-264.00	-34.78	-181.14	12.35
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-7.68	-190.72	20.08	-178.93	15.84
Provision for Tax	0.00	-2.51	1.66	-3.09	6.57
Profit after Tax (Net Income)	-7.87	-188.21	17.88	-175.85	9.27
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Shareholder's Funds	6.74	607.04	1,260.78	160.40	270.49
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.16	39.17	186.25	8.50	104.25
Current Liabilities	3.10	428.58	275.21	54.30	93.25
Total Liabilities	6.40	1,172.38	1,753.10	233.72	499.81

Assets ($ Mln)

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Non-Current Assets	0.58	160.76	183.02	21.30	187.30
Current Assets	9.41	914.04	1,553.41	201.90	280.69
Total Assets	6.40	1,172.38	1,753.10	233.72	499.81
Total Debt*	0.28	254.58	94.51	21.00	113.30
Net Current Assets	0.00	485.45	0.00	147.60	187.44

Cashflow ($ Mln)

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Cash From Operating Activities	-6.43	-150.79	-64.66	-121.18	54.71
Cash Flow from Investing Activities	-0.13	307.87	-29.41	-1.37	26.25
Cash from Financing Activities	7.83	72.35	7.84	276.18	1.50
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
ROCE (%)	-245.41	-18.15	41.92	-130.25	0.77
ROE (%)	-155.31	-28.46	1.43	-106.84	3.39
ROA (%)	-54.57	-12.55	0.66	-74.77	1.69
EBIT Margin (%)	-142.48	-41.09	-6.33	--	8.34
Net Margin (%)	-148.04	-41.86	3.26	--	2.53
Cash Profit Margin (%)	0.00	0.00	--	--	0.00

Growth Ratios

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Revenue Growth (%)	65.22	5.10	-8.81	-1.00	-99.61
EBIT Growth (%)	-7.46	11.36	-76.55	-45.21	523.06
Net Profit Growth (%)	-9.73	11.44	-96.17	-43.04	-99.68
EPS Growth (%)	22.05	-1.87	-96.17	7.30	-96.78
Book Value Growth (%)	11.32	-25.05	2.54	108.85	7.71

Valuation Ratios

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Price / Earnings	-5.29	-11.11	5.08	-9.99	469.58
Price / Book Value	12.13	2.73	1.88	8.70	4.83
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-4.79	-9.39	-25.58	-9.30	36.65
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Debt to Equity	0.00	0.00	0.00	0.00	0.34
Short term debt to equity ratio	0.02	0.40	0.02	0.09	0.03
Current Ratio	3.04	2.13	5.64	3.72	3.01
Quick Ratio	2.95	1.92	5.50	3.72	2.31
Interest Coverage	-72.63	-30.87	-19.05	--	2.08

Operating Efficiency Ratios

	Neuraxis Inc (NRXS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Debtors to sales (%)	8.14	16.23	21.41	--	15.55
Asset Turnover	0.37	0.30	0.20	0.00	0.67
Receivable days	22.53	77.60	104.79	--	51.78
Inventory Days	97.80	109.55	49.57	--	492.02
Payable days	238.88	231.78	47.68	650.68	466.91
Cash Conversion Cycle	-118.55	-44.63	106.67	--	76.89

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly